BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 11854273)

  • 1. Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders.
    Ghosh A; Chen F; Thakur A; Hong H
    CNS Neurosci Ther; 2016 Dec; 22(12):943-951. PubMed ID: 27542570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of montelukast sodium on tendon healing: An experimental study.
    Polat A; Canbora MK; Akakin D; Aykanat F
    Indian J Orthop; 2013 Sep; 47(5):500-4. PubMed ID: 24133311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
    Kanaoka Y; Maekawa A; Austen KF
    J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.
    Barrett NA; Fernandez JM; Maekawa A; Xing W; Li L; Parsons MW; Austen KF; Kanaoka Y
    J Immunol; 2012 Nov; 189(9):4556-65. PubMed ID: 23002438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis.
    Oyoshi MK; He R; Kanaoka Y; ElKhal A; Kawamoto S; Lewis CN; Austen KF; Geha RS
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4992-7. PubMed ID: 22416124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell signalling by reactive lipid species: new concepts and molecular mechanisms.
    Higdon A; Diers AR; Oh JY; Landar A; Darley-Usmar VM
    Biochem J; 2012 Mar; 442(3):453-64. PubMed ID: 22364280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of normal and Haemophilus influenzae-infected mucosal complementary DNA libraries in chinchilla middle ear mucosa.
    Kerschner JE; Erdos G; Hu FZ; Burrows A; Cioffi J; Khampang P; Dahlgren M; Hayes J; Keefe R; Janto B; Post JC; Ehrlich GD
    Ann Otol Rhinol Laryngol; 2010 Apr; 119(4):270-8. PubMed ID: 20433028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
    Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
    Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).
    Chebolu S; Wang Y; Ray AP; Darmani NA
    Eur J Pharmacol; 2010 Feb; 628(1-3):195-201. PubMed ID: 19941848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
    Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
    Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.
    Beller TC; Friend DS; Maekawa A; Lam BK; Austen KF; Kanaoka Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3047-52. PubMed ID: 14970333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
    Martin V; Sawyer N; Stocco R; Unett D; Lerner MR; Abramovitz M; Funk CD
    Biochem Pharmacol; 2001 Nov; 62(9):1193-200. PubMed ID: 11705452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
    Maekawa A; Kanaoka Y; Lam BK; Austen KF
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cysteinyl leukotriene receptors.
    Evans JF
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):117-22. PubMed ID: 12895594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution.
    Ogasawara H; Ishii S; Yokomizo T; Kakinuma T; Komine M; Tamaki K; Shimizu T; Izumi T
    J Biol Chem; 2002 May; 277(21):18763-8. PubMed ID: 11854273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
    Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
    J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.